These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12459317)

  • 1. Study of proliferation and apoptosis in neuroblastoma. Their relation with other prognostic factors.
    del Carmen Mejía M; Navarro S; Pellín A; Ruíz A; Castel V; Llombart-Bosch A
    Arch Med Res; 2002; 33(5):466-72. PubMed ID: 12459317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis in peripheral neuroblastic tumors. Immunohistochemical expression of bcl-2 and p53 is related to DNA fragmentation.
    Mejía C; Navarro S; Llombart-Bosch A
    Histol Histopathol; 2007 Dec; 22(12):1365-70. PubMed ID: 17701916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2.
    Nguyen VN; Mirejovský P; Mirejovský T; Melínová L; Mandys V
    Acta Histochem; 2000 Aug; 102(3):323-38. PubMed ID: 10990069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between Apoptotic Activity and Prognostic Factors in Neuroblastomas.
    Ekmekci S; Olgun N; Özer E
    Turk Patoloji Derg; 2016; 32(2):99-104. PubMed ID: 27136108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of apoptosis and proliferation markers in progression of ovarian cancer].
    Antoneeva II; Petrov SB
    Patol Fiziol Eksp Ter; 2008; (4):6-7. PubMed ID: 19198263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial association of apoptosis-related gene expression and cellular death in clinical neuroblastoma.
    Hoehner JC; Gestblom C; Olsen L; Påhlman S
    Br J Cancer; 1997; 75(8):1185-94. PubMed ID: 9099968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p53, PCNA, Ki-67 and bcl-2 in relation to risk factors in oral cancer - a molecular epidemiological study.
    Schildt EB; Nylander K; Eriksson M; Hardell L; Magnusson A; Roos G
    Int J Oncol; 2003 Apr; 22(4):861-8. PubMed ID: 12632080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl-2 expression.
    Hoehner JC; Hedborg F; Wiklund HJ; Olsen L; Påhlman S
    Int J Cancer; 1995 Jul; 62(1):19-24. PubMed ID: 7601561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of cell proliferation in human neuroblastoma: comparison with other prognostic factors.
    Mejía C; Navarro S; Pellín A; Ruíz A; Castel V; Llombart-Bosch A
    Oncol Rep; 2003; 10(1):243-7. PubMed ID: 12469176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calreticulin expression in neuroblastoma--a novel independent prognostic factor.
    Hsu WM; Hsieh FJ; Jeng YM; Kuo ML; Chen CN; Lai DM; Hsieh LJ; Wang BT; Tsao PN; Lee H; Lin MT; Lai HS; Chen WJ
    Ann Oncol; 2005 Feb; 16(2):314-21. PubMed ID: 15668290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
    Burgues O; Navarro S; Noguera R; Pellín A; Ruiz A; Castel V; Llombart-Bosch A
    Virchows Arch; 2006 Oct; 449(4):410-20. PubMed ID: 16941154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma.
    Sejima T; Miyagawa I
    Eur Urol; 1999; 35(3):242-8. PubMed ID: 10072628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN/ataxia telangiectasia mutated/p53 pathway.
    Yamaguchi Y; Takenobu H; Ohira M; Nakazawa A; Yoshida S; Akita N; Shimozato O; Iwama A; Nakagawara A; Kamijo T
    Eur J Cancer; 2014 May; 50(8):1555-65. PubMed ID: 24559687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity.
    Laitinen KL; Soini Y; Mattila J; Pääkkö P
    Cancer; 2000 Apr; 88(7):1590-8. PubMed ID: 10738217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 expression in colorectal tumours. Correlation with p53, mdm-2, Rb proteins and proliferation indices.
    Goussia AC; Ioachim E; Agnantis NJ; Mahera M; Tsianos EV
    Histol Histopathol; 2000 Jul; 15(3):667-72. PubMed ID: 10963109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression.
    Baretton GB; Klenk U; Diebold J; Schmeller N; Löhrs U
    Br J Cancer; 1999 May; 80(3-4):546-55. PubMed ID: 10408865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.